Triple-negative breast cancer (TNBC), characterized by the absence of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) expression, represents the most aggressive breast cancer subtype. This evidence concerns the gene PGR and breast carcinoma.